Nemonapride
From Self-sufficiency
File:Nemonapride.png | |
Systematic (IUPAC) name | |
---|---|
N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide | |
Clinical data | |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 75272-39-8 |
ATC code | none |
PubChem | CID 4452 |
Chemical data | |
Formula | C21H26ClN3O2 |
Molar mass | 387.90 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
Nemonapride (Emilace) is a typical antipsychotic approved in Japan for the treatment of schizophrenia. It was launched by Yamanouchi in 1991. Nemonapride acts as a D2 and D3 receptor antagonist.
See also
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (November 2009) |
35px | This drug article relating to the nervous system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Articles lacking sources from November 2009
- Articles with invalid date parameter in template
- All articles lacking sources
- Pyrrolidines
- Benzamides
- Phenol ethers
- Organochlorides
- Nervous system drug stubs
- 2Fix